Loading...
Docoh

Tue. 9 Aug 2022, 4:55pm ET Benzinga Earnings

 

Allogene Therapeutics (NASDAQ:ALLO) reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Earnings

Allogene Therapeutics beat estimated earnings by 14.75%, reporting an EPS of $-0.52 versus an estimate of $-0.61.

Revenue was up $42 thousand from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.02 which was followed by a 1.91% drop in the share price the next day.

 

To track all earnings releases for Allogene Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.